比較SV40驅動和IRES驅動二氫葉酸還原酶的載體在CHO細胞工程中基因放大的差異性

Comparing the Difference of Gene Amplification between SV40-driven dhfr and IRES-driven dhfr Vectors in CHO Cell chromosome Engineering

林世昌(Shih-Chang Lin)

指導教授 ： 吳夙欽

國立清華大學/生命科學院/生物科技研究所/碩士(2006年)

https://doi.org/10.6843/NTHU.2006.00501

摘要

S蛋白在疫苗的研發上扮演了很重要的角色。已知截短的SARS-CoV TW1 病毒株之棘蛋白─ 「STR2」(包含有三個S蛋白片段：S74-253、S294-739和S1129-1255，分子量為88 kDa)可在哺乳動物細胞中被表現出來，其表現主要為以對Endo H酵素敏感的醣蛋白形式(~115 kDa)。為了建立可穩定大量表現STR2蛋白之CHO細胞，這份研究使用了由兩種不同方式驅動dhfr基因表現的載體：ISID由internal ribosome entry site (IRES)驅動dhfr基因，ISIZ由SV40啟動子驅動dhfr基因。逐步提高Methotrexate (MTX)濃度讓STR2基因數伴隨dhfr基因在染色體中放大以期大量表現STR2蛋白，並比較利用兩種載體產生的基因數放大的差異。這份研究除了篩選出STR2表現量高的細胞株作為生產次單元疫苗的利器，並可作為未來設計可放大載體的參考。
哺乳動物細胞因其有轉譯後修飾作用，可以增加重組蛋白的療效、穩定度等，在生技製藥上常被用來生產重組蛋白，又因CHO細胞表現系統可以利用dihydrofolate reductase (dhfr)基因放大來增加產量，因此最被廣泛使用，這份研究即是利用CHO細胞表現嚴重急性呼吸道症候群冠狀病毒(SARS-CoV)的套膜Spike重組蛋白(S蛋白)。

關鍵字

基因放大 ； 中國倉鼠卵巢細胞 ； 急性嚴重呼吸道症候群 ； 棘蛋白質 ； 次單位疫苗 ； 二氫葉酸還原脢

並列摘要

The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is important for vaccine development. A truncated SARS-CoV TW1 S protein, STR2 (88 kDa), carrying three S fragments (S-74-253, S-294-739, and S-1129-1255) could express and show the major form as the Endo H-sensitive (~115 kDa) in CHO cells. To establish stably expressing cell clones, the CHO/dhFr- cells were transfected with two amplifiable vectors, ISID (IRES-driven dhfr) and ISIZ (SV40-driven dhfr), for stepwise MTX selection. The enhancement of the ~115 kDa glycoform generation was observed through gene amplification. After stepwise MTX selection, we can compare the difference of gene amplification between the two vectors in CHO cell chromosome engineering. This study can provide information for development of mammalian cell-based SARS-CoV subunit vaccines, and for amplifiable vectors design to produce recombinant proteins.
Because post-translational modification could improve the efficiency and stability of the recombinant proteins in mammalian cells, mammalian cells are the most common used as host cells to produce biopharmaceuticals. CHO cells, which can amplify target gene following dhfr gene amplification to increase productivity, are used as host cells in this study.

並列關鍵字

gene amplification ； CHO cell ； SARS ； spike protein ； subunit vaccine ； dihydrofolate reductase

參考文獻

Ailor, E., and Betenbaugh, M. J. (1998). Overexpression of a cytosolic chaperone to improve solubility and secretion of a recombinant IgG protein in insect cells. Biotechnol Bioeng 58(2-3), 196-203.

Antoniou, M., Harland, L., Mustoe, T., Williams, S., Holdstock, J., Yague, E., Mulcahy, T., Griffiths, M., Edwards, S., Ioannou, P. A., Mountain, A., and Crombie, R. (2003). Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82(3), 269-79.

Assaraf, Y. G., and Schimke, R. T. (1987). Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry. Proc Natl Acad Sci U S A 84(20), 7154-8.

Babcock, G. J., Esshaki, D. J., Thomas, W. D., Jr., and Ambrosino, D. M. (2004). Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78(9), 4552-60.

Berg, D. T., McClure, D. B., Walls, J. D., Yan, S. B., and Grinnell, B. W. (1991). Viral transformation increases vitamin K-dependent gamma-carboxylation of glutamate. Exp Cell Res 192(1), 32-40.